Coeptis Therapeutics
COEP
COEP
15 hedge funds and large institutions have $3.82M invested in Coeptis Therapeutics in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
26% less capital invested
Capital invested by funds: $5.17M → $3.82M (-$1.35M)
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$52.2K | |
| 2 | +$28.4K | |
| 3 | +$12.7K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.21K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.16K |
Top Sellers
| 1 | -$138K | |
| 2 | -$18.4K | |
| 3 | -$1K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$353 |